Dergiler / Kulak Burun Boğaz ve Baş Boyun Cerrahisi / 2018 / Cilt: 26 - Sayı: 2

The Role of Vitamin D in Patients with Otitis Media with Effusion

Sayfa
33–39
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclu- sion: There is a significant association between 25OHVitaminD deficiency and treatment outcomes of OME.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Vitamin D has multiple functions other than calcium metabolism.
📊
Temel Bulgular & Veri:Material and Methods: This retrospective review of OME with 320 patients was conducted from 2014 to 2016.
💡
Sonuç & Katkı:Conclu- sion: There is a significant association between 25OHVitaminD deficiency and treatment outcomes of OME.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:2014 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: Vitamin D has multiple functions other than calcium metabolism. How- ever, there exists a paucity of data to explain the role of Vitamin D deficiency in patients with otitis media with effusion (OME). Material and Methods: This retrospective review of OME with 320 patients was conducted from 2014 to 2016. The case files of patients with OME were analyzed retrospectively and patients were included in the study if 25(OH)D levels were avail- able. Physician documented visit records were identified and statistical analysis was performed by using SPSS version 21 (IBM, Armonk, NY). Results: Of the initial 320 patients with OME, 67 patients had 25(OH)D levels available. 18 out of 67 patients were excluded from the study based on exclusion criteria further detailed in the study. A total of 30 boys (61.2%) and 19 girls (38.8%) were included with mean age 5.85±2.74 years. The mean 25OHVitaminD level was16.87. 18 of 49 patients had 25OHVitaminD deficiency (Group 1). 31 patients had 25OHVita- minD level ≥15 (Group 2). The mean duration of treatment was 6.83 weeks and 3.80 weeks in Group 1 and Group 2 respectively (p: 0.010). 8 of 18 patients (44.4%) in the Group 1 underwent ventilation tube insertion while 4 of 31 patients (12.9%) underwent ventilation tube insertion in the Group 2 (p: 0.018). There was no statistical significance between the subgroups address- ing to age, sex, primary symptom, history of smoking at home, type of house heating. Conclu- sion: There is a significant association between 25OHVitaminD deficiency and treatment outcomes of OME.

🔖

Bu Makaleye Atıf Yap

DÜNDAR, Y., TİMURKAYNAK, Y., DEMİRBAŞ, E., BİRİNCİ, M., ÖZERGİN, Z., DURSUN, E., AKCAN, F. (2018). The Role of Vitamin D in Patients with Otitis Media with Effusion. Kulak Burun Boğaz ve Baş Boyun Cerrahisi, Cilt: 26 - Sayı: 2, 33–39. https://ajindex.com/articles/346582

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Oudesluys-Murphy AM, van Straaten HL, Bholasingh R, van Zanten GA. Neonatal hearing screening. Eur J Pediatr 1996;155(6):429-35
  2. Erenberg A, Lemons J, Sia C, Trunkel D, Ziring P. Newborn and infant hearing loss: detection and in- tervention. American Academy of Pediatrics. Task Force on Newborn and Infant Hearing, 1998-1999. Pediatrics 1999;103 (2):527-30
  3. Paludetti G, Ottoviani F, Fetoni AR, Zuppa AA, Tor- torolo G. Transient evoked otoacustic emissions (TEOAEs) in newborns: normative data. Int J Pediatr Otorhinolaryngol 1999;47 (3):235-41
  4. Doyle KJ, Burggraaff B, Fujikawa S, Kim J. Newborn hearing screening by otoacustic emissions and au- tomated auditory brainstem response. Int J Pediatr Otorhinolaryngol 1997;41(2):111-9
  5. Sennaroğlu G,Akmese PP. Risk Factors for Hearing Loss and Results of Newborn Hearing Screening in Rural Area Int Adv Otol 2011;7:(3) 343-50
  6. Genç A, Belgin E.Temel Odyoloji.Editör:Koç C. Kulak Burun Boğaz Hastalıkları ve Baş Boyun Cer- rahisi
  7. Baskı. Ankara Güneş Tıp Kitapevleri; 2013.p.73-86
  8. Jakubiková J, Kabátová Z, Závodná M. Identification of hearing loss in newborns by transient otoacoustic emissions. Int J Pediatr Otorhinolaryngol 2003;67(1): 15-8
  9. Türkmen AV, Yiğit Ö, Akkaya E, Uğur E, Kefeciler Z, Gözütok S. [Newborn hearing screening outcomes at Istanul education and research hospital]. İstanbul Med J 2013;14: 175-80
  10. Thompson DC, McPhillips H, Davis RL, Lieu TL, Homer CJ, Helfand M. Universal newborn hearing screening: summary of evidence. JAMA 2001;286 (16):2000-10
  11. Karaca ÇT, Toros SZ, Naiboğlu B, Verim A, Çelebi Ş. [Yenidoğan işitme taraması sonuçlarımız]. Van Tıp Dergisi 2014;21(2):67-71
  12. Genç GA, Başar F, Kayıkçı ME, Türkyılmaz D, Fırat Z, Duran Ö, et al. [Newborn hearing screening out- comes in Hacettepe University]. Çocuk Sağlığı ve Hastalıkları Dergisi 2005;48: 119-24
  13. Özbek E, Atlıhan F, Genel F, Çalkavur Ş, Bayar B, Özcan M. [Hearing screening test results of newborn at high risk for developmental delay]. İzmir Dr Behçet Uz Çocuk Hastalıkları Dergisi 2011;1(1):1-6
  14. Kucur C, Kınış V, Özdem Ş, Kucur SK. [Newborn hearing screening results at Zeynep Kamil women and children diseases education and research hos- pital]. Kulak Burun Boğaz İhtis Derg 2021;22(1):38- 42
  15. Çelik İH, Canpolat FE, Demirel G, Eras Z, Sungur VG, Karaer B, et al. [Zekai Tahir Burak women’s health education and research hospital newborn hearing screening results and asseessment of the patients]. Tür